BD (Becton, Dickinson and Company) today launched the BD Vacutainer Urine Complete Cup Kit, a three-tube collection system that expands and supports broader testing capabilities from a single urine specimen.

The new kit is designed to preserve sample integrity and improve workflow efficiency while reducing exposure risks for healthcare workers and minimizing the need for repeat patient collections. With a third tube design, clinicians can perform greater testing without manually transferring urine or collecting a new sample, helping reduce contamination risks and supporting safer, more efficient patient care, according to BD executives.

“Improving diagnostic accuracy starts long before a sample reaches the lab,” said Bridget Bagnato, worldwide president of Specimen Management at BD. “This kit reflects the innovation we deliver to help clinicians determine effective treatment options through more accurate diagnosis and ultimately support better patient management.”

Urine testing is a critical, non‑invasive tool for diagnosing conditions such as pregnancy, urinary tract infections, metabolic disorders, and cancer, as well as for assessing kidney function. Contaminated or improperly collected specimens can lead to the wrong result, inappropriate treatment, or delayed care. One recent study found that nearly 44% of patients with contaminated urine cultures received inappropriate antibiotic therapy, underscoring the clinical impact of preanalytical errors.ⁱ Closed-system solutions, including products in the BD Vacutainer Urine Collection portfolio, help minimize contamination risk and improve overall efficiency across the urine specimen management continuum for accurate, timely results.

The BD Vacutainer Urine Complete Cup Kit features:

• A sterile urine cup and lid with integrated transfer device
• A tube to support culture and sensitivity testing for detecting and identifying bacteria or fungi causing infection
• A tube to support urinalysis testing for general wellness and signs of disease
• A discard tube that contains no additive
• A castile wipe for patient prep prior to providing the sample

Available in the United States with both Hemogard and conventional stoppered tubes, the kit is compatible with various diagnostic equipment and can support automated workflows.

BD is one of the world’s largest pure-play medical technology companies that strives to drive innovation across medical essentials, connected care, biopharma systems, and interventional. The company develops technologies, services, and solutions that optimize clinical operations and improve patient care. Operating worldwide with more than 60,000 employees, BD delivers billions of products annually. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety, and expand access to healthcare.

Reference
ⁱ Klausing BT, Tillman SD, Wright PW, Talbot TR. The influence of contaminated urine cultures in inpatient and emergency department settings. Am J Infect Control. 2016;44(10):1166-1167. doi:10.1016/j.ajic.2016.03.055.